Glucagon-like peptide-1 effects lipotoxic oxidative stress by regulating the expression of microRNAs

Area of Science:

• Biochemistry
• Molecular Biology
• Endocrinology

Background:

• Free fatty acid (FFA)-induced lipotoxicity causes pancreatic oxidative stress, impacting lipid metabolism and insulin secretion.
• Glucagon-like peptide-1 (GLP-1) is known to have protective effects in metabolic disorders.

Purpose of the Study:

• To investigate the role of GLP-1 in modulating body weight, lipid metabolism, and pancreatic oxidative stress.
• To elucidate the molecular mechanisms, including microRNA regulation, underlying GLP-1's effects on FFA-induced pancreatic stress.

Main Methods:

• Experiments were conducted using C57BL/6 mice and INS-1 cells exposed to FFA.
• GLP-1 treatment was administered at varying doses to assess its effects on gene and microRNA expression.
• Key molecular targets including AMPK, PPARα, CPT1A, SIRT1, SREBP1c, miR-33, and miR-370 were analyzed.

Main Results:

• GLP-1 treatment significantly improved markers of oxidative stress (T-AOC, MDA levels) in the pancreas.
• GLP-1 modulated lipid metabolism by increasing the expression of AMPK, PPARα, CPT1A, and SIRT1, while decreasing SREBP1c, miR-33, and miR-370.
• The effects of GLP-1 were observed at low doses and maintained at higher doses, indicating a robust regulatory role.
• Inhibition of miR-33 and miR-370 upregulated CPT1A and SIRT1, confirming their role in GLP-1's protective mechanism.

Conclusions:

• GLP-1 effectively ameliorates lipotoxic oxidative stress in the pancreas.
• GLP-1 exerts its protective effects by regulating specific microRNAs (miR-33, miR-370) and downstream metabolic pathways.
• This study reveals a novel mechanism for GLP-1 in managing pancreatic health through microRNA-mediated gene expression modulation.